Basics Humacyte, Inc. Common Stock IPO Date: November 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $230.34M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.87% Avg Daily Range (30 D): $0.06 | 4.27% Avg Daily Range (90 D): $0.06 | 3.91% Institutional Daily Volume Avg Daily Volume: 1.67M Avg Daily Volume (30 D): 4.23M Avg Daily Volume (90 D): 4.87M Trade Size Avg Trade Size (Sh.): 187 Avg Trade Size (Sh.) (30 D): 354 Avg Trade Size (Sh.) (90 D): 350 Institutional Trades Total Inst.Trades: 302 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $2.15M Avg Inst. Trade Volume: .33M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.58M Avg Closing Trade (30 D): $7.51M Avg Closing Trade (90 D): $2.95M Avg Closing Volume: 333.72K     News Nov 12, 2025 @ 4:00 PM Strong Earnings and Biotech Resilience Define the ... Source: Na Sep 18, 2025 @ 7:08 PM Russell 2000 Hits All-Time Highs: 8 Stocks Power S... Source: Piero Cingari Aug 11, 2025 @ 11:20 AM Humacyte Posts Q2 Revenue Miss Source: Jesterai Mar 26, 2025 @ 10:18 AM US Stocks Likely To Open Lower After 3-Day Advance... Source: Rishabh Mishra Jan 21, 2025 @ 3:44 PM DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The ... Source: The Law Offices Of Frank R. Cruz Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.11 $-.24 $.28 Diluted EPS $-.11 $-.24 $.28 Revenue $ .75M $ .3M $ .52M Gross Profit $ .49M $ .09M $ .37M Net Income / Loss $ -17.51M $ -37.66M $ 39.14M Operating Income / Loss $ -24.39M $ -29.73M $ -23.18M Cost of Revenue $ .26M $ .21M $ .15M Net Cash Flow $ -68.54M $ -24.82M $ 17.91M PE Ratio